Dr Kirsten Palmer, a senior research fellow and NHMRC emerging leader (EL2) within the School of Clinical Sciences, leads the maternal and perinatal medicine translational research group. Her research seeks to translate promising new therapeutics into the clinical setting with a particular interest in disorders of placentation, such as pre-eclampsia and fetal growth restriction. She has developed a collaborative network, both nationally and internationally, undertaking research that extends from exploring the pathophysiology of these disorders to better inform new clinical advances, through to clinical trials to assess the true potential for improving clinical outcomes. Currently her team are conducting trials to optimise outcomes for babies affected by fetal growth restriction, assess a promising new therapeutic for preeclampsia and also to minimise the impact of birth asphyxia on perinatal outcomes. This is in addition to studies aimed at improving the diagnosis of pre-eclampsia, as well as predicting those women at greatest risk of future cardiovascular morbidity or mortality following pregnancy complications.
Find out more about Dr Kirsten Palmer.